Apollo Endosurgery ROA 2006-2018 | APEN

Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Apollo Endosurgery ROA for the three months ending September 30, 2018 was -33.12%.
Apollo Endosurgery ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.04B $0.10B -33.33%
2018-06-30 $-0.03B $0.11B -27.65%
2018-03-31 $-0.03B $0.10B -26.34%
2017-12-31 $-0.03B $0.11B -27.14%
2017-09-30 $-0.03B $0.11B -33.76%
2017-06-30 $-0.04B $0.09B -51.25%
2017-03-31 $-0.04B $0.09B -81.19%
2016-12-31 $-0.04B $0.10B -133.33%
2016-09-30 $-0.06B $0.00B -180.95%
2016-06-30 $-0.05B $0.01B -150.00%
2016-03-31 $-0.04B $0.01B -116.67%
2015-12-31 $-0.04B $0.11B -98.01%
2015-09-30 $-0.01B $0.01B -83.58%
2015-06-30 $-0.02B $0.02B -75.00%
2015-03-31 $-0.02B $0.02B -77.11%
2014-12-31 $-0.02B $0.02B -72.73%
2014-09-30 $-0.01B $0.03B -53.01%
2014-06-30 $-0.01B $0.02B -59.46%
2014-03-31 $-0.01B $0.02B -42.11%
2013-12-31 $-0.01B $0.02B -31.17%
2013-09-30 $-0.01B $0.02B -31.82%
2013-06-30 $-0.01B $0.02B -22.47%
2013-03-31 $-0.01B $0.02B -22.22%
2012-12-31 $-0.00B $0.03B -13.33%
2012-09-30 $-0.01B $0.02B -24.69%
2012-06-30 $-0.00B $0.02B -14.63%
2012-03-31 $-0.00B $0.02B -6.56%
2011-12-31 $-0.00B $0.02B -42.11%
2011-09-30 $0.00B $0.02B 0.00%
2011-06-30 $-0.00B $0.00B -66.67%
2011-03-31 $-0.01B $0.00B -100.00%
2010-12-31 $-0.00B $0.02B -50.00%
2010-09-30 $-0.00B $0.00B inf%
2010-06-30 $0.01B $0.00B 350.00%
2010-03-31 $0.00B $0.00B 106.67%
2009-12-31 $0.00B $0.00B 69.57%
2009-09-30 $0.00B $0.01B 25.00%
2009-06-30 $-0.01B $0.01B -90.32%
2009-03-31 $-0.01B $0.01B -74.07%
2008-12-31 $-0.01B $0.01B -169.23%
2008-09-30 $-0.01B $0.01B -200.00%
2008-06-30 $-0.02B $0.00B -206.45%
2008-03-31 $-0.02B $0.01B -167.44%
2007-12-31 $-0.02B $0.01B -168.42%
2007-09-30 $-0.01B $0.01B -180.65%
2007-06-30 $-0.01B $0.02B -173.91%
2007-03-31 $-0.01B $0.00B -215.38%
2006-12-31 $-0.01B $0.00B -117.65%
2006-09-30 $-0.01B $0.00B -114.29%
2006-06-30 $-0.01B $0.01B -117.65%
2006-03-31 $-0.00B $0.01B -133.33%
2005-12-31 $-0.00B $0.01B -200.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.071B $0.064B
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.457B 22.01
Intuitive Surgical (ISRG) United States $58.919B 57.97
Edwards Lifesciences (EW) United States $32.745B 35.04
Fresenius Medical Care AG KGaA (FMS) Germany $21.185B 14.32
IDEXX Laboratories (IDXX) United States $17.009B 48.58
ABIOMED (ABMD) United States $14.599B 104.90
DexCom (DXCM) United States $13.065B 0.00
Hologic (HOLX) United States $12.427B 19.18
Teleflex (TFX) United States $11.433B 25.95
Varian Medical Systems (VAR) United States $11.421B 28.42
STERIS (STE) United Kingdom $9.401B 24.94
Masimo (MASI) United States $6.157B 39.92
Penumbra (PEN) United States $4.736B 285.98
LivaNova (LIVN) United Kingdom $4.387B 28.16
Globus Medical (GMED) United States $4.190B 26.26
Integra LifeSciences Holdings (IART) United States $3.928B 19.13
Wright Medical Group (WMGI) Netherlands $3.581B 0.00
Cantel Medical (CMD) United States $3.276B 32.31
Inogen (INGN) United States $3.121B 67.36
Integer Holdings (ITGR) United States $2.609B 21.83
Tandem Diabetes Care (TNDM) United States $2.522B 0.00
Glaukos (GKOS) United States $2.123B 0.00
Halyard Health (AVNS) United States $2.108B 18.99
OPKO Health (OPK) United States $2.088B 0.00
Nevro (NVRO) United States $1.261B 0.00
Tactile Systems Technology (TCMD) United States $1.134B 180.50
Luminex (LMNX) United States $1.133B 41.00
Natus Medical (BABY) United States $1.121B 23.56
Pacific Biosciences Of California (PACB) United States $1.083B 0.00
CryoLife (CRY) United States $1.054B 91.93
Orthofix (OFIX) United States $0.964B 27.83
Intersect ENT (XENT) United States $0.873B 0.00
Accelerate Diagnostics (AXDX) United States $0.867B 0.00
Mesa Laboratories (MLAB) United States $0.832B 49.20
AngioDynamics (ANGO) United States $0.772B 25.05
ViewRay (VRAY) United States $0.716B 0.00
Veracyte (VCYT) United States $0.646B 0.00
TransEnterix (TRXC) United States $0.590B 0.00
AxoGen (AXGN) United States $0.560B 0.00
Si-Bone (SIBN) United States $0.538B 0.00
OrthoPediatrics (KIDS) United States $0.411B 0.00
Quotient (QTNT) Switzerland $0.409B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.396B 0.00
Sientra (SIEN) United States $0.381B 0.00
Fluidigm (FLDM) United States $0.340B 0.00
Accuray (ARAY) United States $0.336B 0.00
GenMark Diagnostics (GNMK) United States $0.335B 0.00
IRadimed (IRMD) United States $0.287B 74.97
SeaSpine Holdings (SPNE) United States $0.278B 0.00
Neuronetics (STIM) United States $0.263B 0.00
RTI Surgical (RTIX) United States $0.261B 41.20
Nuvectra (NVTR) United States $0.260B 0.00
Pulse Biosciences (PLSE) United States $0.248B 0.00
Corindus Vascular Robotics (CVRS) United States $0.228B 0.00
CRH Medical (CRHM) Canada $0.227B 39.13
Helius Medical Technologies (HSDT) United States $0.217B 0.00
T2 Biosystems (TTOO) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.132B 0.00
Ra Medical Systems (RMED) United States $0.120B 0.00
Ekso Bionics Holdings (EKSO) United States $0.106B 0.00
Alphatec Holdings (ATEC) United States $0.079B 0.00
Biosig Technologies (BSGM) United States $0.073B 0.00
EDAP TMS (EDAP) France $0.072B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.064B 0.00
Second Sight Medical Products (EYES) United States $0.063B 0.00
Vermillion (VRML) United States $0.054B 0.00
Electromed (ELMD) United States $0.042B 20.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Titan Medical (TMDI) Canada $0.039B 0.00
Viveve Medical (VIVE) United States $0.037B 0.00
Restoration Robotics (HAIR) United States $0.036B 0.00
ConforMIS (CFMS) United States $0.034B 0.00
Microbot Medical (MBOT) United States $0.030B 0.00
Xtant Medical Holdings (XTNT) United States $0.030B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.024B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Lianluo Smart (LLIT) China $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.015B 72.00
American Shared Hospital Services (AMS) United States $0.014B 10.96
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00